By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Zoom Stock: Growth Issues Remain (Ratings Upgrade) (NASDAQ:ZM)
News

Zoom Stock: Growth Issues Remain (Ratings Upgrade) (NASDAQ:ZM)

News
Last updated: 2023/11/21 at 6:33 AM
By News
Share
7 Min Read
SHARE

After the bell on Monday, we received fiscal third quarter results from Zoom Video Communications (NASDAQ:ZM). Perhaps the biggest pandemic darling, the company has seen its revenue growth rate and stock price fall dramatic from their highs. While shares popped on the initial headline beats reported, the company continues to struggle with revenue growth. I am not ready to suggest today that investors fully buy in to the stock, but also I don’t think it’s time to be bearish right now.

For the period ending in October, Zoom’s fiscal Q3, revenues came in a little under $1.137 billion. This number was a little ahead of the average street estimate, although that consensus had come down from $1.21 billion over the past 12 months. The company usually issues okay to soft guidance (more on that later), which sets up beats down the road, as only two top line misses have been reported in the past five years.

After peaking at 369% during the height of the coronavirus sales boom, revenue growth has almost hit zero. The latest quarterly figure was just 3%, and it is quite easy to see why. As the graphic below shows, a number of key metrics continue to grow at much slower rates than in the past. As I detailed in my most recent article on the name, deferred revenues have also started to decline a bit, limiting near term revenue upside.

Key Metrics

Zoom Key Metrics (Company Earnings Reports)

The number of Zoom customers with over $100,000 in trailing twelve month revenues saw its weakest growth since the coronavirus hit. If the recent pattern continues, it is possible in a couple of quarters that this very important number may actually decline, which some investors might see as a major red flag. The growth in Zoom’s Enterprise segment also continued to trend towards the flat line, with the net dollar expansion rate also hitting its lowest point in several years.

The one positive here is that Zoom is a very profitable company, and adjusted operating margins expanded nicely by 4.7 percentage points over the prior year period. On a non-GAAP basis, Zoom delivered over $401 million in net income, up from $323 million in the Q3 2023 period. This resulted in Q3 non-GAAP EPS of $1.29, which handily beat the street by $0.21, continuing an earnings beat streak that’s more than five years at this point.

When it comes to guidance, management said total revenue for fiscal Q4 is expected to be between $1.125 billion and $1.130 billion, and revenue in constant currency is expected to be between $1.129 billion and $1.134 billion. This headline (unadjusted) guidance was a little light, as estimates were calling for $1.13 billion, and that number has of course come down quite a bit in recent quarters. While the company did raise its full year forecast, the range was only increased by about the amount it beat its Q3 guidance by. Of course, it could be setting up another beat down the line. However, I should also note that deferred revenue trends seen below aren’t looking great, so near term revenue upside seems to be limited at this point.

Deferred Revenues

Deferred Revenue Growth (Company Earnings Reports)

The company has one of the best balance sheets out there, with cash and investments of about $6.5 billion at the end of the most recent quarter. Free cash flow in the first nine months of the fiscal year was over $1.13 billion, up more than 10% over the first three quarters of the previous year. This solid cash generation allowed Zoom to buy back some stock last year in an effort to offset dilution from stock-based compensation. There haven’t been any share repurchases this year, which means the share count is rising again, so it will be interesting to see if that cash pile is used for buybacks again soon or perhaps some acquisitions as a way to bolster revenue growth.

In the past, I’ve been bearish on Zoom, but I’m upgrading the name to a hold today. While revenue growth trends aren’t great, the company has not seen a major hit to profitability recently despite the top line stagnation, and it is still generating a ton of cash. Those funds will be put to use at some point, and the stock trades for about 14 times next fiscal year’s expected adjusted EPS. While you won’t get a lot of growth here, that valuation number is only about half of what the big tech names like Apple (AAPL), Alphabet (GOOG) (GOOGL), and Microsoft (MSFT) average right now.

I also think that a name like Zoom might generate more interest again in 2024. The stock soared during the pandemic, but crashed once revenue growth rates initially came down. That valuation further compressed as the Fed hiked interest rates over the last year plus, but those days seem to be in the rear view mirror. Zoom can’t really be lopped in with the “unprofitable tech” trade because it has significant profitability. With the market actually expecting the Fed to cut rates next year, Zoom’s large cash pile and decent valuation make it hard to bet against currently.

However, I will evaluate my rating again as we get more results in, because if these revenue trends completely rollover, the stock could be back in sell territory again. In the end, it was another mixed quarter for Zoom with headline beats, mixed guidance, and weakening key metrics. This name is a cash flow monster with a decent valuation. For that reason, I can’t keep a sell rating at this point, but this company is by no means on the impressive list either.

Read the full article here

News November 21, 2023 November 21, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

HTD: Tax-Advantaged Monthly Income From Dividends (NYSE:HTD)

By News
News

Globe Trade Centre S.A. 2025 Q3 – Results – Earnings Call Presentation (OTCMKTS:GBCEY) 2025-12-05

By News
News

Zumiez Inc. (ZUMZ) Q3 2025 Earnings Call Transcript

By News
News

Celebrus Technologies plc (DFORF) Q2 2026 Earnings Call Transcript

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?